Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - Medicine Man Technologies, Inc. MDCL, will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound.
For more information and/or to register for the conference please visit: https://benzingacannabisconference.com/chicago/?utm_source=newsfile&utm_medium=press_release&utm_campaign=newsfile
Past and future Cannabis Capital Conferences will have heard from luminaries making headlines and disrupting the industry, including:
Bruce Linton | Executive Chairman at Gage Cannabis
Kevin Murphy | Chairman & CEO at Acreage Holdings
Charlie Bachtell | CEO & Co-Founder at Cresco Labs
Kim Rivers | CEO at Trulieve
Hadley Ford | CEO at iAnthus
Brian Schinderle | CFO at Grassroots
Gary Allen | COO at New Frontier Data
Will Stuart | SVP at Harvest One
Josh Genderson | Founder & CEO at Holistic Industries
Rob Kelly | Director of IR at Aurora Cannabis
Peter Miller | CEO at SLANG Worldwide
The 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 is the premier gathering of cannabis entrepreneurs and investors in North America. No other conference offers the level of access and seamlessness of interaction between entrepreneurs building future billion-dollar cannabis enterprises and the investors whose capital will make that happen.
About Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. provides cultivation consulting services for cannabis growing technologies and methodologies. The company also provides licensing and seminar services. In addition, it engages in retail operations of cannabis products. The company was founded in 2014 and is based in Denver, Colorado.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48592
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.